G-protein-coupled receptor dimerization: Modulation of receptor function

Pharmacology and Therapeutics

Volumn 92, Issue 2-3, 2001, Pages 71-87

  Rios, C D ^a   Jordan, B A ^a   Gomes, I ^a   Devi, L A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioluminescence resonance energy transfer; Desensitization; GPCR maturation; Oligomerization; Opioids; Protein protein interaction

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AZIDO 5 IODONEMONAPRIDE; ALPHA 2C ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BRADYKININ B2 RECEPTOR; CALCIUM SENSING RECEPTOR; COMPLEMENTARY DNA; CYAN FLUORESCENT PROTEIN; CYCLIC AMP; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DIMER; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; EPITOPE; ETORPHINE; G PROTEIN COUPLED RECEPTOR; GONADORELIN RECEPTOR; GREEN FLUORESCENT PROTEIN; IODINE DERIVATIVE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; LIGAND; M PROTEIN; MU OPIATE RECEPTOR; MUSCARINIC M3 RECEPTOR; OLIGOMER; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOPRESSIN V2 RECEPTOR;

BINDING AFFINITY; BIOLUMINESCENCE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CROSS LINKING; DIMERIZATION; ENDOCYTOSIS; ENERGY TRANSFER; FLUORESCENCE; IMMUNOPRECIPITATION; LIGAND BINDING; MACROMOLECULE; MOLECULAR WEIGHT; NEUROMODULATION; OLIGOMERIZATION; PRIORITY JOURNAL; REVIEW;

DIMERIZATION; ENDOCYTOSIS; GTP-BINDING PROTEINS; HUMANS; LIGANDS; NARCOTICS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 0035726693     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(01)00160-7     Document Type: Review

References (118)

1. 2 receptor in agonist-induced receptor dimerization
2. 1 receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
3. Ig-hepta, a novel member of the G protein-coupled hepta-helical receptor (GPCR) family that has immunoglobulin-like repeats in a long N-terminal extracellular domain and defines a new subfamily of GPCRs
4. Regulation of stably transfected platelet activating factor receptor in RBL-2H2 cells. Role of multiple G proteins and receptor phosphorylation
5. 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)
6. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: Subunit assembly may explain high- and low-affinity agonist states
7. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells
8. Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function
9. Specific antibody to the thyrotropin receptor identifies multiple receptor forms in membranes of cells transfixed with wild-type receptor complementary deoxyribonucleic acid: Characterization of their relevance to receptor synthesis, processing, structure, and function
10. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5-Δ32
11. Serpentine receptors for parathyroid hormone, calcitonin and extracellular calcium ions
12. Solubilization and characterization of adrenal and uterine angiotensin II receptors after photoaffinity labeling
13. Physicochemical characterization of photoaffinity-labeled angiotensin II receptors
14. Homer-1c/Vesl-1L modulates the cell surface targeting of metabotropic glutamate receptor type 1α: Evidence for anchoring function
15. Muscarinic receptor size on smooth muscle cells and membranes
16. Radiation inactivation (target size analysis) of the gonadotropin-releasing hormone receptor: Evidence for a high molecular weight complex
17. Conversion of a gonadotropin-releasing hormone antagonist to an agonist
18. Gonadotropin-releasing hormone receptor microaggregation: Rate monitored by fluorescence resonance energy transfer
19. Expanding horizons for receptors coupled to G proteins: Diversity and disease
20. Dimerization of the delta opioid receptor: Implication for a role in receptor internalization
21. Model systems for the study of seven-transmembrane-segment receptors
22. +2 receptor: Effects on cell surface expression, dimerization and signal transduction
23. Evidence for adenosine/dopamine receptor interactions: Indications for heteromerization
24. 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography
25. Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells
26. 3H-spiroperidol binding in rat striatum: Evidence for increased affinity and reduction in number of binding sites
27. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy
28. Muscarinic cholinergic receptors in embryonic chick heart: Interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist 3H-cis-methyldioxolane
29. Characterization of the subunit structure of the thyrotropin receptor in the FRTL-5 rat thyroid cell line
30. A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization
31. Oligomerization of the mu and delta opioid receptors
32. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
33. 1 receptors form functionally interacting heteromeric complexes
34. Expression, purification and biochemical characterization of the amino-terminal extracellular domain of the human calcium receptor
35. Heterodimerization of the mu and delta opioid receptors: A role in opiate synergy
36. 2-adrenergic receptor that exploits the domain structure of G-protein coupled receptors
37. Domain swapping in G-protein coupled receptors
38. Dimerization and domain swapping in G-protein-coupled receptors: A computational study
39. Binding of [3H] SKF 38393 to dopamine D-1 receptors in rat striatum in vitro: Estimation of receptor molecular size by radiation inactivation
40. Immunoprecipitation isolates multiple TSH receptor forms from human thyroid tissue
41. Analysis of the adrenal angiotensin II receptor with the photoaffinity labeling method
42. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: Dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely
43. Increased biological activity of dimers of oxymorphone and enkephalin: Possible role of receptor cross-linking
44. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation
45. 2-AR through receptor dimerization
46. Specificity of receptor-G protein interactions: Searching for the structure behind the signal
47. Dimerization of cell surface receptors in signal transduction
48. A kinetic model for oxotremorine M binding to recombinant porcine M2 muscarinic receptors expressed in Chinese hamster ovary cells
49. Biological actions of monoclonal luteinizing hormone/human chorionic gonadotropin receptor antibodies
50. BR2
51. G-protein-coupled receptor heterodimerization modulates receptor function
52. Kappa opioid receptor endocytosis by dynorphin peptides
53. Oligomerization of opioid receptors with β2 adrenergic receptors: A role in trafficking and mitogen activated protein kinase activation
54. B-receptor subtypes assemble into functional heteromeric complexes
55. Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer
56. B receptor function
57. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
58. Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors: Structure-function relationship with special reference to the human VIP-1 receptor
59. Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell
60. Selective modulation of wild type receptor functions by mutants of G-protein coupled receptors
61. Sequence specificity in the dimerization of transmembrane α-helices
62. Negative cooperativity among beta-adrenergic receptors in frog erythrocyte membranes
63. Beta-adrenergic receptors: Evidence for negative cooperativity
64. Beta-adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system
65. Co-expression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein linked receptors
66. Functional role of the third cytoplasmic loop in muscarinic receptor dimerization
67. G protein-linked receptors: Pharmacological evidence for the formation of heterodimers
68. B receptor heterodimerization
69. B receptors - The first 7TM heterodimers
70. Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting
71. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
72. Molecular size of opiate (enkephalin) receptors in neuroblastoma-glioma hybrid cells as determined by radiation inactivation analysis
73. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer: The human delta-opioid receptor displays constitutive oligomerization at the cell surface which is not regulated by receptor occupancy
74. Phosphorylation and palmitoylation of human D2L dopamine receptor in Sf9 cells
75. Dopamine D2 receptor dimers and receptor-blocking peptides
76. B receptor activity
77. Structure of the thyrotropin receptor and thyroid adenylate cyclase system as determined by target analysis
78. 3 receptor dimers and tetramers in brain and in transfected cells
79. Target size analysis of opioid receptors. No difference between receptor types, but discrimination between two receptor states
80. G-protein-coupled receptors function as oligomers in vivo
81. 236
82. Covalent cross-linking of angiotensin II to its binding sites in rat adrenal membranes
83. Crystal structure of rhodopsin: A G-protein coupled receptor
84. Affinities of different cholinergic agonists for the high and low affinity states of hippocampal M1 muscarinic receptors
85. Two affinity states of M1 muscarinic receptors
86. Evidence for paired M2 muscarinic receptors
87. Characterization of the dimerization of metabotropic glutamate receptors using an N-terminal truncation of mGluR1α
88. Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity
89. Subtypes of the somatostatin receptor assemble as functional homo and heterodimers
90. The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2
91. Luteinizing hormone receptors are self-associated in the plasma membrane
92. High affinity angiotensin II receptors in myocardial sarcolemmal membranes. Characterization of receptors and covalent linkage of 125I-angiotensin II to a membrane component of 116,000 daltons
93. Hydrodynamic properties of the angiotensin II receptor from bovine adrenal zona glomerulosa
94. Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in membranes from rat hippocampus
95. Morphine tolerance increases mu-noncompetitive delta binding sites
96. beta-FNA binds irreversibly to the opiate receptor complex: In vivo and in vitro evidence
97. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: Further evidence for two mu-binding sites
98. Functional significance of oligomerization of G protein-coupled receptors
99. Towards understanding the glycoprotein hormone receptors
100. In vitro mutagenesis and the search for structure-function relationships among G-protein coupled receptors
101. Locating ligand-binding sites in 7TM receptors by protein engineering
102. Molecular characterization of muscarinic receptor subtypes in bovine cerebral cortex by radiation inactivation and molecular exclusion HPLC
103. Solubilization and partial characterization of angiotensin II receptors from rat brain
104. Hydrodynamic parameters of opioid receptors from frog brain
105. Structure and function of G protein-coupled receptors
106. B heterodimer as the functional receptor
107. Dimerization of TFIID when not bound to DNA
108. Molecular size of the human platelet a2-adrenergic receptor as determined by radiation inactivation
109. Monoclonal antibodies against luteinizing hormone receptor. Immunochemical characterization of the receptor
110. Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro
111. G-protein-coupled receptors: Molecular mechanisms involved in receptor activation and selectivity of G-protein recognition
112. B receptor
113. Steroid hormone receptors: Evolution, ligands, and molecular basis of biologic function
114. Cooperativity manifest in the binding properites of purified cardiac muscarinic receptors
115. Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed
116. Dopamine D2 receptor dimers in human and rat brain
117. Identification and molecular characterization of M3 muscarinic receptor dimers
118. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function